NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 49 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,274 | -57.2% | 21,751 | +3.7% | 0.00% | – |
| Q2 2023 | $54,333 | -31.8% | 20,978 | +7.5% | 0.00% | -100.0% |
| Q1 2023 | $79,609 | -17.1% | 19,512 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $96,002 | -61.1% | 19,124 | +1.3% | 0.00% | -50.0% |
| Q3 2022 | $247,000 | +5.1% | 18,874 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $235,000 | -1.7% | 18,351 | +17.3% | 0.00% | +100.0% |
| Q1 2022 | $239,000 | -19.5% | 15,643 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $297,000 | -18.0% | 16,744 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $362,000 | +4.0% | 17,245 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $348,000 | -20.2% | 17,655 | +17.7% | 0.00% | -50.0% |
| Q1 2021 | $436,000 | +3.8% | 14,995 | +8.2% | 0.00% | 0.0% |
| Q4 2020 | $420,000 | +85.0% | 13,861 | -2.8% | 0.00% | +100.0% |
| Q3 2020 | $227,000 | -19.8% | 14,259 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $283,000 | +59.0% | 14,357 | -0.7% | 0.00% | 0.0% |
| Q1 2020 | $178,000 | -37.1% | 14,455 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $283,000 | +371.7% | 15,289 | +254.3% | 0.00% | – |
| Q3 2019 | $60,000 | -4.8% | 4,315 | +0.9% | 0.00% | – |
| Q2 2019 | $63,000 | – | 4,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 16,245,817 | $247,749,000 | 45.93% |
| Ponoi II Management, LLC | 1,298,908 | $19,808,000 | 43.96% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $57,442,000 | 39.74% |
| Ponoi Management, LLC | 1,298,908 | $19,808,000 | 25.71% |
| Euclidean Capital LLC | 746,674 | $11,387,000 | 6.62% |
| StepStone Group LP | 1,573,357 | $23,994,000 | 1.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,494 | $3,058,000 | 1.26% |
| First Light Asset Management, LLC | 816,653 | $12,454,000 | 1.10% |
| BVF INC/IL | 955,000 | $14,564,000 | 0.58% |
| HighVista Strategies LLC | 46,243 | $705,000 | 0.45% |